AstraZeneca PLC Director Appointment


2025-10-28SEC Filing 6-K (0001654954-25-012271)

AstraZeneca PLC announced that Euan Ashley, a Non-Executive Director of the Company, has been appointed as a director of DexCom, Inc. effective from 24 October 2025. This announcement is made pursuant to Listing Rule 6.4.9 (2). AstraZeneca is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals. The company's innovative medicines are sold in over 125 countries and used by millions of patients worldwide.


Tickers mentioned in this filing:AZN